PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A‐mediated cell cycle progression

Table 1 Clinic-pathological characteristics of enrolled patients

Clinicopathological characteristics	Total (n = 49)	PTBP3		P-value
Clinicopathological characteristics	Total (n = 49)	High^a (n = 13)	Low^a (n = 36)	P-value
Age				0.682
≤ 60	25	6	19
> 60	24	7	17
Gender				0.742
Male	31	9	22
Female	18	4	14
Differentiation				0.449
Low	22	7	15
Moderate and High	27	6	21
Tumor size				0.029*
> 3 cm	25	10	15
≤ 3 cm	24	3	21
Lymph node metastasis				0.39
Positive	20	4	16
Negative	29	9	20
Distant metastasis				–
M0	49	13	36
M1	0	0	0

^aHigh and low expression groups were determined by the cutoff-point 25% (13 of 49) and 75% (36 of 49) of PTBP3 in 49 tumor tissue specimens
*Statistical significance (P < 0.05)

ISSN: 1475-2867